EPM2A Peptide

CAT: 0544-MBS152586-01Size: 0.05 mgDry Ice: NoHazardous: No
CAT#:0544-MBS152586-01Size:0.05 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Gene Name
[EPM2A]
NCBI Gene ID
7957
Storage Conditions
Store EPM2A peptide at -20 °C, stable for one year.
Other Gene Names
[EPM2A; EPM2A; EPM2; MELF; LAFPTPase]
Short Name
[EPM2A]
Other Product Names
[laforin isoform a; Laforin; laforin; EPM2A; LAFPTPase; lafora PTPase; glucan phosphatase; epilepsy, progressive myoclonus type 2, Lafora disease (laforin); epilepsy, progressive myoclonus type 2A, Lafora disease (laforin); Glucan phosphatase; Lafora PTPase; LAFPTPase]
NCBI GI Number
11321613
NCBI Accession Number
NP_005661
NCBI GB Accession Number
NM_005670.3
Uniprot Accession Number
O95278

Related Products

CatalogName
MBS428429-01EPM2A (laforin) IP1 Immunizing Peptide
MBS8536175-01EPM2A
MBS9220873-01EPM2A Antibody (C-term) Blocking Peptide
MBS200112-01EPM2A antibody
MBS7046162-01EPM2A Antibody
MBS9410435-01EPM2A Antibody
MBS150261-01EPM2A Antibody
MBS2562573-01EPM2A Polyclonal Antibody
MBS9433921-01EPM2A Polyclonal Antibody
MBS1269942-01EPM2A cDNA Clone

Alternative Products

CatalogName
45-547PEPM2A Peptide
abx269614EPM2A (Laforin) Peptide
AAP63377-100UGEPM2A Peptide - N-terminal region (AAP63377)
AAP63376-100UGEPM2A Peptide - N-terminal region (AAP63376)
148856EPM2A, Control Peptide (Laforin, Lafora PTPase, LAFPTPase, EPM2)
AB-23036-PHuman epilepsy, progressive myoclonus type 2A (EPM2A) Control/blocking peptide
E3384-75D-PEpilepsy, Progressive Myoclonus Type 2A (Lafora Disease, EPM2A, Laforin, LD, LDE, EPM2, MELF, LAFPTPase, FLJ11207, KIAA0766) (Control Peptide) discontinued
ant-427EPM2A
322083-01Laforin (EPM2A)
OACA09370-50UGEPM2A Antibody

Popular Products